The emerging role of USP29 in cancer and other diseases
Cell Biochemistry and Function · 2024
DOI: 10.1002/cbf.3928 ↗At a glance
Übersichtsarbeit in Cell Biochemistry and Function, 2024. Written by Ru Zhang and 6 co-authors. Institution: Department of Gastroenterology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Major MEDLINE topics: Neoplasms. Cited 2 times so far (Crossref); 48 references. Funded by: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (original language)
Reversible protein ubiquitination is a key process for maintaining cellular homeostasis. Deubiquitinases, which can cleave ubiquitin from substrate proteins, have been reported to be deeply involved in disease progression ranging from oncology to neurological diseases. The human genome encodes approximately 100 deubiquitinases, most of which are poorly characterized. One of the well‐characterized deubiquitases is ubiquitin‐specific protease 29 (USP29), which is often upregulated in pathological tissues and plays important roles in the progression of different diseases. Moreover, several studies have shown that deletion of Usp29 in mice does not cause visible growth and developmental defects, indicating that USP29 may be an ideal therapeutic target. In this review, we provide a comprehensive summary of the important roles and regulatory mechanisms of USP29 in cancer and other diseases, which may help us better understand its biological functions and improve future studies to construct suitable USP29‐targeted therapy systems.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Gastroenterology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Department of Cancer Precision Medicine, The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Funding
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Cite
APA
Zhang, R., Cai, Z., Ren, D., Kang, Y., Zhang, Q., Lu, X., & Tu, R. (2024). The emerging role of USP29 in cancer and other diseases. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.3928
Vancouver
Zhang R, Cai Z, Ren D, Kang Y, Zhang Q, Lu X, et al. The emerging role of USP29 in cancer and other diseases. Cell Biochemistry and Function. 2024. doi:10.1002/cbf.3928
BibTeX
@article{Zhang2024,
author = {Zhang, Ru and Cai, Zeqiong and Ren, Doudou and Kang, Ye and Zhang, Qi and Lu, Xinlan and Tu, Rongfu},
title = {The emerging role of USP29 in cancer and other diseases},
journal = {Cell Biochemistry and Function},
year = {2024},
doi = {10.1002/cbf.3928}
}
EUVIMED